Regenerative Medicine: Learning from Past Examples
Name
Couto-2012-Regenerative medicine.pdf
Size
300.48 KB
Format
Adobe PDF
Checksum (MD5)
4ad56f44474f546a9eef1fad9ed85c14
Author(s)
Couto, Daniela S.
Perez-Breva, Luis
Cooney, Charles L.
Date Issued
June 2012
Journal
Tissue Engineering. Part A
Publisher
Mary Ann Liebert
Citation
Couto, Daniela S., Luis Perez-Breva, and Charles L. Cooney. “Regenerative Medicine: Learning from Past Examples.” Tissue Engineering Part A (2012): 120725085622009. Copyright © 2012 Mary Ann Liebert, Inc. publishers.
Version
Final published version
Abstract
Regenerative medicine products have characteristically shown great therapeutic potential, but limited market success. Learning from the past attempts at capturing value is critical for new and emerging regenerative medicine therapies to define and evolve their business models as new therapies emerge and others mature. We propose a framework that analyzes technological developments along with alternative business models and illustrates how to use both strategically to map value capture by companies in regenerative medicine. We analyze how to balance flexibility of the supply chain and clarity in the regulatory pathway for each business model and propose the possible pathways of evolution between business models. We also drive analogies between cell-based therapies and other healthcare products such as biologicals and medical devices and suggest how to strategically evolve from these areas into the cell therapy space.
MIT Department
Massachusetts Institute of Technology. Center for Biomedical Innovation
Massachusetts Institute of Technology. Department of Chemical Engineering
Terms of Use
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1089/ten.TEA.2011.0639
